ECE2017 Eposter Presentations: Diabetes, Obesity and Metabolism Obesity (81 abstracts)
Comparative study between laparoscopic gastric bypass and laparoscopic sleeve gastrectomy
Aurora Aragón-Alonso , Mercedes Ferrer Gómez , José Ramón Cuenca Sánchez , David Ruiz de Angulo Martín , María Dolores Frutos Bernal , María Ángeles Campillo Espallardo , Pedro Segura Luque & Antonio Hernández Martínez
Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
Introduction: Bariatric surgery is currently considered the most effective treatment for morbid obesity. Laparoscopic gastric bypass (LGB) and laparoscopic sleeve gastrectomy (LSG) are the most widely used bariatric procedures today.
Objectives: In this study we compared LGB and LSG in order to establish whether there is any superiority of one or the other in effectiveness and complications.
Methods: We included all the patients who underwent bariatric surgery in Hospital Universitario Virgen de la Arrixaca during one year (n=101) of which 62 received LGB and 39 LSG. Both groups were comparable in age, body max index, rates of hypertension (HT), type 2 DM (T2DM), hypercholesterolemia (Hchol), hypertriglyceridemia (HTG) and obstructive sleep apnea syndrome (OSA). A higher percentage of women was present in the LGB group. We retrospectively compared postoperative complications and excess weight loss (EWL) and comorbidity resolution (HT, T2DM, Hchol, HTG and OSA) at one year after surgery.
Results: LGB was superior to LSG in HT remission (75% vs 43.8%, P=0.046) and Hchol remission (96.3% vs 33.3%, P<0.001). We found no significant differences between LGB and LSG regarding EWL (77.7%±23.3 vs 76.9%±17.8), T2DM remission (78.6% vs 75%), HTG resolution (86.7% vs 75%) and OSA remission (55.6% vs 16.7%). Also, both techniques were comparable regarding rate of postoperative complications (17.7% vs 10.3%).
Conclusions: At one year postsurgery, LGB was superior to LSG in HT and Hchol remission. However, both techniques are comparable in terms of safety, weight loss and resolution of other comorbidities (T2DM, HTG and OSA).
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more